Q3 2025 Earnings Call Transcript November 14, 2025 Operator: Good morning, everyone. Thank you for standing by, and welcome to BIO-key International’s Third Quarter 2025 Conference Call. [Operator Instructions] As a reminder,

Partnership enables BIO-key technologies to be localized and delivered across Vietnam via SAVIS Group’s trusted services platformHANOI, Vietnam and HOLMDEL, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- BIO-key International,

DALLAS, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its third quarter 2025 financial results and provided a corporate update.

PALO ALTO, Calif.--(BUSINESS WIRE)--Peak Bio, Inc. ("Peak Bio" or the "Company") (NASDAQ: PKBO), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory diseases, today ...

Climb Bio, Inc., a clinical-stage biotechnology company focused on therapies for immune-mediated diseases, has announced the appointments of Dr. Edgar D. Charles as Chief Medical Officer and Cindy J. Driscoll as Senior Vice President of Finance. Dr ...

Neok Bio Inc. was formed earlier this year and is already on schedule to file an IND in a few months for its two bispecific antibody-drug conjugates (ADCs) to treat various types of tumors. The biotech got a leg up on development from its principal investor,

We came across a bullish thesis on Nuvation Bio Inc. on wallstreetbets subreddit by asagi_lumina. In this article, we will summarize the bulls’ thesis on NUVB. Nuvation Bio Inc.'s share was trading at $3.2200 as of September 23rd. AbCellera Biologics Inc ...

Upon the closing of the Business Combination, the combined company will operate under the name Instinct Bio Technical Company Holdings Inc. and intends to list its ordinary shares on the NASDAQ Stock Exchange under the ticker symbol ‘ BIOT ’.

Nuvation Bio Inc. (NYSE:NUVB) is one of the 12 Best American Penny Stocks to Buy Right Now. On November 4, Citizens increased its price target on Nuvation Bio Inc.

SAN DIEGO and SUZHOU, China and SPRING HOUSE, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. ('Adagene”) (Nasdaq: ADAG) and Third Arc Bio, Inc. ('Third Arc Bio”), today announced a licensing agreement under which Third Arc Bio will utilize Adagene’s SAFEbody technology platform to generate masked CD3 T cell engagers against unique tumor associated antigens.